Fmoc-Leu-Leu-OH pairs two hydrophobic residues under an N-terminal protecting group, enabling studies of packing effects and backbone orientation. The motif contributes to strong hydrophobic clustering in assembled peptides. Researchers employ it for optimizing resin-bound elongation. Applications span structural modeling, sequence design, and hydrophobic-core engineering.
CAT No: R2530
CAS No:88743-98-0
Synonyms/Alias:Fmoc-leu-leu-OH;88743-98-0;L-Leucine, N-[N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucyl]-;(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid;(2S)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanamido]-4-methylpentanoic acid;(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoyl]amino]-4-methylpentanoic acid;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucyl-L-leucine;N-Fmoc-L-leucyl-L-leucine;Fmoc-Leu-Leu;MFCD01632054;Fmoc-L-Leu-L-Leu-OH;E97UXQ96C2;N-(N-Fmoc-L-leucyl)-L-leucine;CS-0129143;EN300-1521370;L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucyl-;(2S)-2-[(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-4-METHYLPENTANAMIDO]-4-METHYLPENTANOIC ACID;(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-4-methylpentanoicacid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More